Latest news with #AustralianMarket
Yahoo
10-07-2025
- Business
- Yahoo
ARC Capital Venture Analysts Weigh RBA's Pause at 3.85% Amid Mixed Inflation Signals
Australian Market Reactions and Policy Implications Unpacked as ARC Capital Venture Interprets Central Bank's Strategic Hold in a Complex Inflationary Landscape MELBOURNE, AU / / July 9, 2025 / ARC Capital Venture (Australia) Pty Ltd, a specialist fixed income and private market investment firm serving sophisticated Australian investors, provides commentary following the Reserve Bank of Australia's unexpected policy decision. In a decision that surprised markets and defied consensus forecasts, the Reserve Bank of Australia (RBA) opted to hold the official cash rate steady at 3.85%, pausing its easing cycle after two consecutive reductions earlier this year. The move, supported by a 6-3 majority within the board, reflects a nuanced response to a maturing disinflationary trend and resilient domestic demand. Key Takeaways Inflation Trajectory Easing: The RBA acknowledged that underlying inflation has decelerated meaningfully, with core measures reaching 2.4% YoY in May, the lowest level since late 2021. This suggests monetary policy has gained traction, particularly in curbing demand-driven price pressures. Labour Market Remains Robust: Despite a cooling housing sector and patchy retail activity, employment metrics remain strong. The unemployment rate continues to hover near historical lows, and wage growth is proving sticky, providing a buffer to household consumption. Board's Stance: Data-Dependent: For the first time, the RBA published a breakdown of board member votes, signalling a shift toward greater transparency. The majority's preference to pause was framed as a prudent wait-and-see approach ahead of the Q2 CPI release later this month, which will be pivotal in shaping the policy path into year-end. In our view, the RBA's decision marks an inflection point in the easing cycle narrative - one that prioritizes policy credibility over premature accommodation. While inflation appears to be converging toward the 2-3% target range, structural components such as services inflation, housing input costs, and administered pricing remain elevated and could re-accelerate if policy becomes too loose too quickly. "We believe this hold is not an end to easing, but a recalibration. It underscores that further cuts will be contingent on persistent evidence that inflation is not just falling, but staying anchored - particularly in sectors less sensitive to interest rates," said Marios Anastasiou, Chief Executive Officer at ARC Capital Venture (Australia) Pty Ltd. The RBA's approach maintaining optionality while reinforcing its inflation-fighting mandate resonates with recent positioning by other global central banks navigating similar post-peak inflation environments. The market's expectation for up to two more cuts by year-end remains intact, but conviction has clearly diminished. Implications for Investors Bond Markets: Yields on Australian government bonds rose slightly following the announcement, with traders revisiting pricing for a September cut. We continue to see medium-dated government and investment-grade corporate bonds as attractive in this environment, especially as real yields remain positive. Mortgage and Property Sector: While borrowers may feel the disappointment of no immediate relief, we caution against over leveraging in anticipation of imminent rate cuts. Refinancing into more competitive loan packages and managing household liquidity remain prudent. Equities and Allocation: The RBA's pause supports a soft-landing thesis, but earnings sentiment will hinge on real economic momentum and forward inflation reads. We maintain a selective overweight in income-generating equities and defensive sectors that benefit from stable rates. With four more monetary policy meetings scheduled this year - the next on Aug. 12 - investors should brace for a data-dependent and gradualist central bank. The road to "neutral" remains long, but so too does the runway for long-term allocation opportunities in fixed income and quality equities. ARC Capital Venture (Australia) Pty Ltd (ABN 97 687 134 121 | AFS Representative No. 001315577) is a Corporate Authorised Representative of Titan Securities Pty Ltd (AFSL No. 307040). The information contained in this release is general in nature and does not take into account your investment objectives, financial situation or particular needs. Before making any investment decision, you should consider whether the information is appropriate to your circumstances. Investment in financial products involves risk, and past performance is not a reliable indicator of future results. ARC Capital Venture (Australia) Pty Ltd recommends that you seek independent financial, tax, and legal advice before acting on any information provided. Contact Information Max Harrington Head of 3 9998 0440 SOURCE: ARC Capital Venture (Australia) Pty Ltd View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
10-07-2025
- Business
- Yahoo
ASX Penny Stocks Spotlight: Clarity Pharmaceuticals And 2 More Standouts
The Australian market is poised for a rebound, with shares expected to rise following Wall Street's positive momentum, largely driven by Nvidia's remarkable performance. In the context of this optimistic market backdrop, penny stocks—often smaller or newer companies—continue to intrigue investors despite being considered an outdated term. These stocks can offer unique growth opportunities and financial resilience that may not be as prevalent in larger firms. Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.35 A$100.31M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.23 A$105.2M ★★★★★★ GTN (ASX:GTN) A$0.625 A$119.2M ★★★★★★ IVE Group (ASX:IGL) A$2.92 A$450.21M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.735 A$458.75M ★★★★★★ Regal Partners (ASX:RPL) A$2.44 A$820.39M ★★★★★★ Sugar Terminals (NSX:SUG) A$0.99 A$360M ★★★★★★ Navigator Global Investments (ASX:NGI) A$1.71 A$838.04M ★★★★★☆ Bisalloy Steel Group (ASX:BIS) A$4.02 A$190.75M ★★★★★★ CTI Logistics (ASX:CLX) A$1.795 A$144.58M ★★★★☆☆ Click here to see the full list of 465 stocks from our ASX Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company focused on the research and development of radiopharmaceutical products in Australia and the United States, with a market cap of A$895.84 million. Operations: The company's revenue is derived from its radiopharmaceutical development segment, totaling A$10.78 million. Market Cap: A$895.84M Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company with a market cap of A$895.84 million, is pre-revenue and currently unprofitable. Despite this, the company has made significant strides in its development pipeline. Recent agreements like the Commercial Manufacturing Agreement with SpectronRx enhance its manufacturing capabilities for 64Cu-SAR-bisPSMA in the US, potentially positioning it well for commercial rollout pending successful trials and FDA approval. Clarity's robust cash position exceeds both short- and long-term liabilities, providing a runway to continue advancing clinical trials such as AMPLIFY and DISCO without incurring debt. Unlock comprehensive insights into our analysis of Clarity Pharmaceuticals stock in this financial health report. Assess Clarity Pharmaceuticals' future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: IGO Limited is an exploration and mining company in Australia that focuses on discovering, developing, and operating assets related to metals for clean energy, with a market cap of A$3.32 billion. Operations: The company's revenue is primarily derived from its Nova Operation, which generated A$460.8 million, and its Forrestania Operation, contributing A$153 million. Market Cap: A$3.32B IGO Limited, with a market cap of A$3.32 billion, operates primarily through its Nova and Forrestania operations, generating significant revenues of A$460.8 million and A$153 million respectively. Despite being unprofitable and having a negative return on equity, IGO's financial health is bolstered by its debt-free status and strong asset position, with short-term assets significantly exceeding both short- and long-term liabilities. The company is trading well below estimated fair value but faces challenges with an inexperienced management team averaging one year in tenure. Recent executive changes aim to bolster sustainability efforts within the company. Dive into the specifics of IGO here with our thorough balance sheet health report. Evaluate IGO's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Stanmore Resources Limited is involved in the exploration, development, production, and sale of metallurgical coal in Australia with a market cap of A$1.85 billion. Operations: The company generates revenue of $2.40 billion from its metals and mining segment, specifically through coal. Market Cap: A$1.85B Stanmore Resources, with a market cap of A$1.85 billion, generates substantial revenue of $2.40 billion from its metallurgical coal operations. Despite facing challenges such as a decline in profit margins from 16.8% to 8% and negative earnings growth over the past year, the company benefits from well-covered debt by operating cash flow and satisfactory net debt to equity ratio (1%). Recent events include being dropped from key indices like the S&P/ASX 200, which might impact investor sentiment. The management team is experienced, although earnings are forecasted to decline significantly over the next three years. Get an in-depth perspective on Stanmore Resources' performance by reading our balance sheet health report here. Learn about Stanmore Resources' future growth trajectory here. Access the full spectrum of 465 ASX Penny Stocks by clicking on this link. Contemplating Other Strategies? Explore 27 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:CU6 ASX:IGO and ASX:SMR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
09-07-2025
- Business
- Yahoo
ASX Insights 3 Stocks That May Be Trading Below Their Estimated Value
The Australian market has recently been shaped by fluctuating commodity prices and sector-specific movements, with utilities outperforming while real estate lagged following the RBA's pause. In this environment, identifying undervalued stocks can be crucial for investors seeking opportunities; these are often characterized by strong fundamentals that may not yet be reflected in their current market price. Name Current Price Fair Value (Est) Discount (Est) Ridley (ASX:RIC) A$2.89 A$5.78 50% PointsBet Holdings (ASX:PBH) A$1.185 A$2.10 43.6% Nuix (ASX:NXL) A$2.05 A$3.32 38.3% Lindsay Australia (ASX:LAU) A$0.71 A$1.15 38.5% Integral Diagnostics (ASX:IDX) A$2.57 A$4.57 43.8% Infomedia (ASX:IFM) A$1.215 A$2.07 41.3% Fenix Resources (ASX:FEX) A$0.2825 A$0.50 44% Collins Foods (ASX:CKF) A$9.12 A$15.84 42.4% Charter Hall Group (ASX:CHC) A$19.12 A$35.43 46% Advanced Braking Technology (ASX:ABV) A$0.084 A$0.16 48.9% Click here to see the full list of 36 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. Overview: Domino's Pizza Enterprises Limited operates retail food outlets and has a market capitalization of A$1.77 billion. Operations: Revenue for Domino's Pizza Enterprises comes from its restaurant operations, totaling A$2.30 billion. Estimated Discount To Fair Value: 37.5% Domino's Pizza Enterprises appears undervalued, trading at A$18.78 against a fair value estimate of A$30.03, suggesting potential for appreciation based on cash flow analysis. Despite challenges with low profit margins and high debt levels, earnings are forecast to grow significantly at 32.9% annually over the next three years, outpacing the broader Australian market. Recent leadership changes aim to bolster performance and strategic execution amidst ongoing global restructuring efforts. In light of our recent growth report, it seems possible that Domino's Pizza Enterprises' financial performance will exceed current levels. Dive into the specifics of Domino's Pizza Enterprises here with our thorough financial health report. Overview: Genesis Minerals Limited focuses on the exploration, production, and development of gold deposits in Western Australia, with a market cap of A$4.57 billion. Operations: The company generates revenue of A$561.40 million from its activities in mineral production, exploration, and development. Estimated Discount To Fair Value: 37.9% Genesis Minerals is trading at A$4.04, significantly below its estimated fair value of A$6.51, highlighting potential undervaluation based on cash flows. The company's earnings and revenue are forecast to grow at 26.7% and 21% per year, respectively, outpacing the Australian market growth rates. Genesis recently appointed Jane Macey as a Non-Executive Director, bringing extensive industry experience that could support strategic growth initiatives amidst this promising financial outlook. The analysis detailed in our Genesis Minerals growth report hints at robust future financial performance. Click here to discover the nuances of Genesis Minerals with our detailed financial health report. Overview: Regis Healthcare Limited provides residential aged care services in Australia and has a market cap of A$2.25 billion. Operations: The company's revenue is primarily derived from its residential aged care services, amounting to A$1.10 billion. Estimated Discount To Fair Value: 28.6% Regis Healthcare, trading at A$7.46, is significantly undervalued with a fair value estimate of A$10.45. The company's earnings are projected to grow 24.9% annually, surpassing the Australian market's growth rate of 10.9%. Despite slower revenue growth at 8.1% per year compared to its earnings, Regis became profitable this year and exhibits strong potential for future financial performance based on cash flow analysis and return on equity forecasts. The growth report we've compiled suggests that Regis Healthcare's future prospects could be on the up. Click here and access our complete balance sheet health report to understand the dynamics of Regis Healthcare. Unlock our comprehensive list of 36 Undervalued ASX Stocks Based On Cash Flows by clicking here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:DMP ASX:GMD and ASX:REG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
08-07-2025
- Business
- Yahoo
Kogan.com And Two Other ASX Penny Stocks To Watch
The Australian market is poised for a slight retreat, with traders eyeing potential impacts from international tariff tensions and awaiting the Reserve Bank's decision on interest rates. Amidst these broader economic shifts, investors often seek opportunities in lesser-known sectors that could offer unique growth prospects. Penny stocks, though considered niche today, remain relevant as they represent smaller or newer companies that may provide significant returns when supported by strong financials. In this context, we explore three promising penny stocks on the ASX worth watching for their balance sheet strength and potential long-term success. Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.365 A$104.6M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.40 A$113.22M ★★★★★★ GTN (ASX:GTN) A$0.64 A$122.06M ★★★★★★ IVE Group (ASX:IGL) A$2.92 A$450.21M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.70 A$449.5M ★★★★★★ Sugar Terminals (NSX:SUG) A$0.99 A$363.6M ★★★★★★ Navigator Global Investments (ASX:NGI) A$1.73 A$847.84M ★★★★★☆ Accent Group (ASX:AX1) A$1.49 A$895.77M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$4.03 A$191.22M ★★★★★★ CTI Logistics (ASX:CLX) A$1.80 A$144.98M ★★★★☆☆ Click here to see the full list of 469 stocks from our ASX Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Ltd is an online retailer based in Australia, with a market capitalization of A$388.32 million. Operations: Ltd generates revenue through its operations in Australia, with A$309.36 million from Kogan Parent and A$9.96 million from Mighty Ape, and in New Zealand, with A$40.02 million from Kogan Parent and A$124.88 million from Mighty Ape. Market Cap: A$388.32M Ltd, with a market capitalization of A$388.32 million, is trading significantly below its estimated fair value. Despite negative earnings growth of 73.9% over the past year and declining profits over five years, the company remains debt-free with sufficient short-term assets to cover both short and long-term liabilities. Recent executive changes include appointing Belinda Cleminson as Company Secretary. The company extended its buyback plan duration until May 2026, indicating confidence in future performance despite current challenges such as low profit margins and a dividend not well covered by earnings. Earnings are forecasted to grow annually by 34.52%. Jump into the full analysis health report here for a deeper understanding of Review our growth performance report to gain insights into future. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Platinum Investment Management Limited is a publicly owned hedge fund sponsor with a market cap of A$278.22 million. Operations: The company generates revenue primarily from Funds Management, contributing A$157.13 million, with an additional A$4.63 million from Investments and Other activities. Market Cap: A$278.22M Platinum Investment Management Limited, with a market cap of A$278.22 million, is trading at 32.6% below its fair value estimate, suggesting potential undervaluation. The company remains debt-free and has robust short-term assets (A$169.7M) exceeding liabilities, yet faces challenges with declining earnings and lower profit margins compared to last year. Despite high-quality earnings and stable volatility, the dividend yield of 6% isn't well covered by current earnings. The management team is experienced; however, the board's average tenure suggests inexperience. Recent M&A discussions may impact future strategic direction amidst forecasted earnings decline of 10.4% annually over three years. Click to explore a detailed breakdown of our findings in Platinum Investment Management's financial health report. Learn about Platinum Investment Management's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Sheffield Resources Limited focuses on the evaluation and development of mineral sands in Australia, with a market cap of A$78.96 million. Operations: Sheffield Resources Limited has not reported any specific revenue segments. Market Cap: A$78.96M Sheffield Resources Limited, with a market cap of A$78.96 million, is pre-revenue and unprofitable, experiencing increasing losses over the past five years. Despite this, it has no debt and a solid cash runway exceeding three years if free cash flow growth continues at historical rates. The company's short-term assets (A$8.4M) comfortably cover its short-term liabilities (A$310K), indicating sound liquidity management. Its board of directors is considered experienced with an average tenure of 5.1 years, although there's insufficient data on management experience. Earnings are forecast to grow significantly at 79.69% annually despite current challenges. Take a closer look at Sheffield Resources' potential here in our financial health report. Gain insights into Sheffield Resources' outlook and expected performance with our report on the company's earnings estimates. Embark on your investment journey to our 469 ASX Penny Stocks selection here. Interested In Other Possibilities? Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:KGN ASX:PTM and ASX:SFX. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
07-07-2025
- Automotive
- Yahoo
ASX Value Stocks That May Be Trading Below Estimated Worth In July 2025
As the Australian market navigates the complexities of international trade tensions and sector-specific developments, investors are keenly observing how these factors influence overall market performance. In this environment, identifying stocks that may be trading below their estimated worth can provide opportunities for those looking to capitalize on potential value investments. Name Current Price Fair Value (Est) Discount (Est) Ridley (ASX:RIC) A$2.90 A$5.78 49.8% PointsBet Holdings (ASX:PBH) A$1.185 A$2.10 43.4% Pantoro Gold (ASX:PNR) A$3.06 A$5.50 44.3% Integral Diagnostics (ASX:IDX) A$2.53 A$4.57 44.7% Infomedia (ASX:IFM) A$1.26 A$2.07 39.2% Fenix Resources (ASX:FEX) A$0.28 A$0.51 44.6% Domino's Pizza Enterprises (ASX:DMP) A$18.02 A$29.57 39.1% Collins Foods (ASX:CKF) A$8.79 A$15.62 43.7% Charter Hall Group (ASX:CHC) A$19.36 A$35.43 45.4% Advanced Braking Technology (ASX:ABV) A$0.083 A$0.16 49.5% Click here to see the full list of 37 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. Overview: Infomedia Ltd is a technology company that develops and supplies electronic parts catalogues, service quoting software, and e-commerce solutions for the automotive industry worldwide, with a market cap of A$475.51 million. Operations: The company's revenue primarily comes from its Publishing - Periodicals segment, which generated A$142.41 million. Estimated Discount To Fair Value: 39.2% Infomedia is trading at A$1.26, significantly below its estimated fair value of A$2.07, indicating it may be undervalued based on cash flows. However, its 3.33% dividend yield isn't well covered by earnings due to large one-off items impacting results. While revenue growth is modest at 6.9% annually, earnings are expected to grow nearly 20% per year, surpassing the Australian market average of 10.9%. Analysts anticipate a potential stock price increase of over 40%. Upon reviewing our latest growth report, Infomedia's projected financial performance appears quite optimistic. Click to explore a detailed breakdown of our findings in Infomedia's balance sheet health report. Overview: PointsBet Holdings Limited operates a cloud-based technology platform offering sports, racing, and iGaming betting products and services in Australia, with a market cap of A$399.15 million. Operations: The company generates revenue through its Canadian Trading segment, contributing A$36.24 million, and its Australian Trading segment, which brings in A$216.01 million. Estimated Discount To Fair Value: 43.4% PointsBet Holdings is trading at A$1.19, well below its estimated fair value of A$2.10, suggesting it might be undervalued based on cash flows. The company is forecast to become profitable within three years with earnings expected to grow significantly, outpacing the average market growth. Despite slower revenue growth at 10.5% annually compared to a higher benchmark, PointsBet's return on equity is projected to be very high in three years' time at 59.7%. According our earnings growth report, there's an indication that PointsBet Holdings might be ready to expand. Dive into the specifics of PointsBet Holdings here with our thorough financial health report. Overview: Web Travel Group Limited offers online travel booking services across Australia, the United Arab Emirates, the United Kingdom, and internationally with a market cap of A$1.62 billion. Operations: The company generates revenue primarily through its Business to Business Travel (B2B) segment, which accounts for A$328.40 million. Estimated Discount To Fair Value: 29.6% Web Travel Group is trading at A$4.49, below its fair value estimate of A$6.37, indicating undervaluation based on cash flows. Earnings are projected to grow significantly at 31.92% annually, surpassing the Australian market average growth rate. However, profit margins have decreased to 3.4% from last year's 24.6%, and insider selling has been significant recently. Recent board changes include the addition of experienced directors Melanie Wilson and Paul Scurrah, potentially strengthening governance. Our comprehensive growth report raises the possibility that Web Travel Group is poised for substantial financial growth. Take a closer look at Web Travel Group's balance sheet health here in our report. Delve into our full catalog of 37 Undervalued ASX Stocks Based On Cash Flows here. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:IFM ASX:PBH and ASX:WEB. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
